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ABSTRACT
Objective: Recent progress in genetic analysis and investigations have enabled researchers  to identify potential genetic changes that may play a role 
in ASD. The number of genes connected with autism is growing. Whole exome sequencing(WES) identified the homozygous TBC1D8 variant. Aim to 
report for the first time a TBC1D8 missense variant (c.1883G>A, p. (Arg628Gln) in 4 Libyan children (3 homozygous,1 heterozygous) with severe 
neurodevelopmental phenotypes ASD and intellectual disability ID . Based on the data of HGMD and ClinVar, variants in only a few autosomal recessive 
intellectual disability ARID genes seem to be reported frequently. 
Method: Molecular genetic analysis of (WES) was carried out on blood samples from these children. The outcome of the genetic investigations  was 
interpreted within the context of clinical finding, family history, and suspected mode of inheritance.
Results: The number of genes associated with autism is increasing. WES identified the TBC1D8 variant. According to the longest isoform 
(NM_001102426.1),the nomenclature of this variant is c.1883G>A, p. (Arg628Gln) in TBC1D8 which leads to an amino acid exchange. This variant has 
not previously reported or described in the literature (PubMed, HGMD).
Conclusion: we have provided evidence for a connection between TBC1D8 variant and ASD and ID; however, this evidence should be considered 
preliminary in the context of a single case report and such findings need to be replicated to gain insight in order to determine if ASD and ID are a 
characteristic of this variant.
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INTRODUCTION
TBC1 Domain Family Member 8 (TBC1D8) is a Protein Coding gene. Cell 
cycle is one of the gene-associated pathways. Annotations linked to gene 
ontology (GO) include calcium ion binding and activation of GTPase. 
An important paralog of this gene is TBC1D8B (HGNC: 17791) (GCID: 
GC02M101007).The chromosome location is 2q11.2. No more than 
a few of the novel ID genes seem to share to molecular pathways and 
networks that have been earlier involved in dominant and X-linked forms 
of ID, such as pre-and post-synaptic signaling, transcription regulation, 
and epigenetic mechanisms [1-3]. The only exemption is UBE2J2 
encoding a ubiquitin-conjugating enzyme, which symbolizes an evolving 
mechanism for controlling synapse function by post-translational 
alteration through the ubiquitin pathway at the postsynaptic membrane 
[4]. Proteolysis by the ubiquitin proteosome pathway is recognized as 
a major molecular pathway leading to several neurodevelopmental and 
neurodegenerative diseases [5]. Previously identified gene networks that 
are commonly disrupted in IDand other neurodevelopmental disorders 
are composed of genes that are highly dosage-sensitive. Therefore, these 
pathways might indicate other neurobiological activities than those 
that are affected by recessive mutations [6]. In this article we report 
for the 1st time a homozygous TBC1D8 missense variant (c.1883G>A, 
p. (Arg628Gln) in 3 Libyan children with severe neurodevelopmental 
phenotypes (ASD) and (ID). Surprisingly, the fourth sibling carries 
the TBC1D8 variant in heterozygous state. According to the American 
Association on Intellectual and Developmental Disabilities, Intellectual 
disability is at present is regarded as “a disability associated with 
significant restrictions both in intellectual functioning and in adaptive 
behavior as expressed in conceptual, social, and practical adaptive skills. 
This disability originates before age 18” [7]. Moreover, newly published 
DSM-5 uses the term “intellectual developmental disorder” as the 
alike term for “intellectual disability” because forthcoming ICD-11 will 
probably use the term “intellectual developmental disorder” to show 
involvement of compromised brain functioning earlyin life [8]. Autistic 
spectrum disorder (ASD) comprises a group of neurobiological disorders 
that are characterized by deficits in social interaction and communication 
and by abnormalities in behaviors, interests, and activities [8]. ASD has 
a complex genetic etiology, and monogenic disorders associated with 
the high penetrance of ASD are observed in less than 20% of ASD cases. 
Well-known single-gene disorders associated with ASD are Fragile X 
syndrome, Rettsyndrome, MECP2 duplication, Angelman syndrome, and 
Tuberous sclerosis [9].
NewUSA government survey (2014) of parents suggests that 1 
in 45 children aged 3 through 17 had been diagnosed with ASD. This is 
remarkably higher than the formal government approximate of 1 
in 68 American children with autism, as stated by National Center 
for Health Statistics [10]. One prospective hospital-based study 
conducted on all children referred to the neurodevelopment clinic at 
Al-Khadra Teaching Hospital, Tripoli, Libya between 2005 and 2009 for 
ASD evaluation showed a prevalence of one in 300 [11]; yet again in 
the 2011 study 200 children were referred for ASD evaluation because 
of their behavioral difficulties and speech and language disorders. ASD 
was diagnosed in 83% of cases (166 children) which gives a prevalence 
of 10:1000 [12,13]. The prevalence of the problem in Libya is probably 
higher or similar to that seen in the USA and UK.
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.
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METHODS
These four Libyan children were born to non-blood-related parents at 
term after uneventful pregnancy. Parents provided informed signed 
consent for genetic studies on blood samples from their children. The 
outcome of the genetic investigations was interpreted in the context of 
clinical finding, family history, and suspected mode of inheritance.
Children
Child 1 (girl) was the first sib. She is now 12 year old. Delayed 
developmental milestones including speech and language were noted 
since early infancy. At the age of 1 year: she was noted to have poor 
eye to eye contact; and the diagnosis of (ASD) and (ID) was made 
at 2 years of age. Child 2 (girl) is the second sib who is now 10 years 
old. Developmental delay was noted since early infancy. At the age 
of 20 months, her eye-to-eye contact was still absent. No seizures were 
reported. Speech was absent; and the diagnosis of (ASD) and (ID) were 
made at 4 years of age. Child 3 (boy) is the third sib who is now 9 years 
old. Developmental delay was also noted since early infancy. At the age 
of 18 months, his eye contact was absent. No seizures were reported. 
Speech was absent; and the diagnosis of (ASD) and (ID) was made 
at 5 years of age. Child 4 (girl) is the fourth sib who is now 7 years 
old. Developmental delay was noted since early infancy. At the age 
of 24 months, she was noted to have inconsistent imitation skills. Eye 
contact was absent. No seizures were reported. Speech was absent; and 
the diagnosis of (ASD) and (ID) was made at 5 years of age.
Genetic studies
Molecular genetic analysis of whole-exome sequencing (WES) was 
carried out at Bioscientia Institute for Medical Diagnostics Gmbh, Center 
for Human Genetics, Ingelheim, Germany. More than 20,000 genes of 
the patients DNA were enriched and sequenced.Filtering of the exome 
data targeted recessive, X-linked, and dominantly inherited disease. 
Genomic DNA was fragmented and the exons of the known gene in 
the human genome, as well as corresponding exon-intron boundaries, 
were enriched using Roche Nimble Gen capture technology(SeqCap 
MedExome Library)amplified and sequenced simultaneously by 
illumina technology(next-generation sequencing NGS) using an 
illumina system. The target regions were sequenced with average 
coverage of 164 fold. For about 97% of the regions of interest a 
15-fold coverage, for about 95% a 20-fold coverage was obtained. NGS 
data were aligned to the hg19 genome assembly. Variant calling and 
annotation were performed by an in-house developed bioinformatics 
pipeline identified single-nucleotide variants and indels were filtered 
against external and internal database focusing on rare variants 
with minor allele frequency in gnomAD of 1% or less and removing 
known artifact and variants in regions with highly homologous 
regions. Classification of variants was conducted based on ACMG 
guidelines considering database entries (incl.HGMD), bioinformatics 
prediction tools, and literature status [14]. A change of pathogenicity 
classifications over time cannot be excluded from the study. Variants 
annotated as common polymorphisms in databases or literature or that 
were classified as (likely) benign were neglected. Putatively pathogenic 
differences between the wild type sequence (human reference genome 
according to (UCSC Genome Browser: hg19, GRCh37) and the patients 
sequence mentioned and interpreted in this report were assessed using 
an in-house established quality score. Variants not passing the quality 
threshold were verified using polymerase chain reaction amplification 
followed by conventional Sanger sequencing. Sample identity was 
ensured by internal quality management procedures. The laboratory 
Quality management is also recognized and accredited by the Central 
Office of the Federal States for Health Protection for Drugs and Medical 
Devices (ZLG), German accreditation body (DAkkS) and College of 
American Pathologists. The recorded data in paper and/or in electronic 
form are stored in accordance with the legal requirements and their 
use and/or publication should be in pseudonymized form for scientific 
purposes. Confidentiality is maintained. Any sample material that 
remaining at the end of the analysis is transferred, in accordance with 
§950 BGBI (Germany’s official gazette of federal law).
DIAGNOSIS AND MANAGEMENT
ASD and ID were established as follows: First, according to history, 
parent interview and neurodevelopmental symptoms, including 
cognition, motor performance, hearing, speech, and vision; second, 
through assessment of intelligence quotient (IQ) using a standardized 
tests (IQ below 70); third, according to limitations in environment 
adaptation, including self-care and skills of communication [15,16]. 
Neurodevelopmental assessment with the help of the vineland 
established adaptive behavior scale (VABS), DSM5, Modified checklist 
of autism in children(M-CHAT), and Conner’s Autism Rating Scale 
revealed that the children were suffering from autism along with severe 
ID with an IQ score of about 25–30 [17-19].
Auditory brainstem response showed normal hearing.EEG revealed 
no abnormal epileptic activities; and MRI brain showed normal brain 
structure with no evidence of encephalopathy, degenerative changes, 
or atrophy. Their complete blood pictures, urea and electrolytes, liver 
and thyroid function tests, and creatinine kinase were normal. The 
metabolic screen including serum bicarbonate, arterial blood gases, 
Vitamin D and B12 were normal. Molecular genetic analysis of WES 
identified the homozygous missense variant in the TBC1D8 gene in the 
entire children (Table 1).
RESULTS
The number of genes related with autism is increasing [20]. 
WES identified the homozygous TBC1D8 variant. The following 
is NCBI Reference Sequence: LOCUS: NM_001102426 (4226 
bp - mRNA - linear - PRI 07-MAY-2020) DEFINITION: Homo sapiens 
TBC1D8, transcript variant 2, mRNA. ACCESSION: NM_001102426 
VERSION: NM_001102426.2 KEYWORDS: RefSeq. SOURCE: Homo 
sapiens (human) The nomenclature of this variant is c.1883G>A, p. 
(Arg628Gln) in TBC1D8 which leads to an amino acid exchange. Eight 
out 10 bioinformatic in silico programs predict a pathogenic effect 
for this variant. In silico analysis of the variant showed that 17 out 
of 30 tools predicted a possible pathogenicity (Prediction [17/30] = 
Functional [11/22] + Conservation [6/8]). While many deleteriousness 
prediction methods have been developed, their prediction results 
are sometimes not in agreement with each other. The predictive 
performance of 18 current deleteriousness-scoring methods was 
comprehensively evaluated, including 11 function prediction scores 
(PolyPhen-2, SIFT, MutationTaster, Mutation Assessor, FATHMM, LRT, 
PANTHER, PhD-SNP, SNAP, SNPs&GO and MutPred), 3 conservation 
scores (GERP++, SiPhy, and PhyloP) and 4 ensemble scores (CADD, 
PON-P, KGGSeq, and CONDEL). It has been found that FATHMM and 
KGGSeq had the maximum discriminative power among independent 
scores and ensemble scores, respectively [21]. This variant has not 
formerly been reported or described in the literature (PubMed, 
HGMD). The variant is found in 0.0014% of the whole population(4 
heterozygous,0 homozygous; X hemizygous; GnomAD). (Riazuddin and 
his colleagues reported a c.1501C>T, p. (Leu501Phe) variant of TBC1D8 
in a Punjabi consanguineous family (PKMR66) among the other 30 
novel candidate genes for autosomal recessive intellectual disability 
(ARID) with neither epilepsy nor ASD (Table 2) [6].
DISCUSSION
A global prevalence of (ASD) was estimated on review of epidemiological 
studies and has been found to be increasing [22]. Improvements in 
genetic analysis have offered the ability to recognize potential genetic 
variations that may contribute to ASD. Remarkably, based on the data 
of HGMD and ClinVar, variants in only a few ARID genes appear to be 
reported frequently. The large ARID studies that were executed on over 
100 families none of them showed any remarkably prevalent gene in 
ARID. It isextremelysignificant totake note that the final conclusion 
from molecular genetic analysis of WES must not end with laboratory 
classification or grouping of a variant or variants. For example, the 
classification of a variant of unknown significance (VUS) from a 
laboratory should be further evaluated in the clinical setting. With 
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increased and betterunderstanding over time of phenotypes linked to 
different genetic disorders, exome reanalysis may change the clinical 
interpretation of a VUS [23]. Homozygous mouse models (Tbc1d8 em1 
[IMPC] J/Tbc1d8 em1 [IMPC] J) showed abnormal behavior, cataract 
and male infertility(MGI Reference; 1927225 ID = J:188991) [24,25]. 
Numerous existing techniques for pathway examination rely upon 
prevailing databases. The information utilized is not in every case 
totally clarified. Many genes interactions in databases are somewhat 
theoretical as they depend on scientific facts and are pulled from a 
particular cell type or illness. In addition, most authoritative pathways 
are manufactured utilizing the information got from an inadequate 
number of analyses with limited cell models [26]. This series of four 
Libyan siblings with ASD and ID; sum-ups novel presentations of a 
variant in protein coding genes TBC1D8 (c.1883G>A, p. (Arg628Gln). 
The four siblings had what appeared to be similar presentation of ASD 
at initial assessment and have continued through the similar clinical 
course, progressed in the same way but regrettably they have been 
making slow and disappointing progress despite very good educational 
input. Generally speaking, these four cases provide novel presentations 
of ASD and ID and highlight the importance ofWES investigations. To 
our knowledge, the variant has not been described in the literatures 
so far. The variant is found in 0.0014% of the overall population (4 
heterozygous, 0 homozygous; X hemizygous,gnomAD). Taken together, 
it is clear that the detected homozygous TBC1D8 variant may contribute 
to the phenotype of these siblings.
CONCLUSION
In this article, we have provided evidence for a plausible connection 
between TBC1D8 variant and ASD and ID; however, this evidence 
should be considered preliminary within the framework of a single 
case report of four siblings and such findings need to be replicated in 
order to determine if ASD and ID are a characteristic of this variant; 
indeed, we report these findings to encourage other clinicians and 
professionals to look for such variants when dealing with children who 
suffers from ASD and ID. Theawareness, understanding and knowledge 
about the causes of human genetic disorders constantly improve due to 
the continuous identification of novel disease genes.
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